Skip to main content
Veterinary Medicines

Tylovectin 200 Solution for Injection for Cattle, Goats and Pigs

Authorised
  • Tylosin

Product identification

Medicine name:
TYLOVECTIN 200 SOLUTION FOR INJECTION FOR CATTLE, GOATS AND PIGS.
Tylovectin 200 Solution for Injection for Cattle, Goats and Pigs
Active substance:
  • Tylosin
Target species:
  • Cattle
  • Pig
  • Goat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Tylosin
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        108
        hour
    • Pig
      • Meat and offal
        16
        day
    • Goat
      • Meat and offal
        42
        day
      • Milk
        108
        hour
  • Intravenous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • VM 30282/4045
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0323/001
Concerned member states:
  • Belgium
  • Netherlands
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."